PONTISSO, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.890
AS - Asia 12.468
EU - Europa 8.607
AF - Africa 2.917
SA - Sud America 2.866
OC - Oceania 309
Continente sconosciuto - Info sul continente non disponibili 163
Totale 57.220
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.394
SG - Singapore 3.659
CN - Cina 2.876
HK - Hong Kong 2.360
BR - Brasile 1.922
FI - Finlandia 1.222
PL - Polonia 1.064
DE - Germania 1.060
IT - Italia 897
VN - Vietnam 601
SE - Svezia 507
RU - Federazione Russa 449
FR - Francia 369
UA - Ucraina 269
GB - Regno Unito 258
IN - India 189
AT - Austria 178
IE - Irlanda 165
NL - Olanda 160
TR - Turchia 160
AR - Argentina 144
MX - Messico 134
EC - Ecuador 125
ZA - Sudafrica 114
IQ - Iraq 111
ES - Italia 110
MA - Marocco 110
UZ - Uzbekistan 110
CI - Costa d'Avorio 108
CO - Colombia 105
CZ - Repubblica Ceca 102
LB - Libano 101
MN - Mongolia 98
AL - Albania 97
AZ - Azerbaigian 97
ID - Indonesia 95
KZ - Kazakistan 93
SA - Arabia Saudita 93
JO - Giordania 90
JP - Giappone 90
PE - Perù 90
PR - Porto Rico 90
KG - Kirghizistan 89
NP - Nepal 88
CA - Canada 87
PK - Pakistan 87
EE - Estonia 86
EG - Egitto 86
AE - Emirati Arabi Uniti 85
CY - Cipro 85
LA - Repubblica Popolare Democratica del Laos 85
ME - Montenegro 85
PY - Paraguay 85
TN - Tunisia 85
CL - Cile 84
DZ - Algeria 84
BY - Bielorussia 83
CW - ???statistics.table.value.countryCode.CW??? 83
BF - Burkina Faso 81
GT - Guatemala 81
TT - Trinidad e Tobago 81
BA - Bosnia-Erzegovina 80
DO - Repubblica Dominicana 80
KR - Corea 80
LC - Santa Lucia 80
UY - Uruguay 80
BE - Belgio 79
BZ - Belize 79
IL - Israele 79
PS - Palestinian Territory 79
RO - Romania 79
CR - Costa Rica 78
JM - Giamaica 78
LV - Lettonia 78
MD - Moldavia 78
MK - Macedonia 78
NO - Norvegia 78
PH - Filippine 78
RS - Serbia 78
CG - Congo 77
GF - Guiana Francese 77
GR - Grecia 77
LY - Libia 77
BO - Bolivia 76
CV - Capo Verde 76
PA - Panama 76
VE - Venezuela 76
IR - Iran 75
NI - Nicaragua 75
TJ - Tagikistan 75
AU - Australia 74
GN - Guinea 74
HN - Honduras 74
AO - Angola 73
BB - Barbados 73
HR - Croazia 73
ML - Mali 73
SI - Slovenia 73
GH - Ghana 72
KE - Kenya 72
Totale 53.663
Salva come PNG Salva come JPEG
Città #
Fairfield 3.804
Jacksonville 2.853
Hong Kong 2.288
Woodbridge 2.117
Singapore 1.896
Wilmington 1.820
Ashburn 1.817
Chandler 1.777
Houston 1.722
Cambridge 1.318
Seattle 1.264
Ann Arbor 1.252
Bytom 966
Boardman 957
Princeton 940
Medford 592
Nanjing 546
Santa Clara 502
San Diego 475
Beijing 471
Helsinki 420
Roxbury 287
Padova 222
Des Moines 218
Dong Ket 205
Guangzhou 205
Los Angeles 170
Shenyang 169
São Paulo 162
Nanchang 160
Buffalo 142
Ho Chi Minh City 142
Munich 142
Hefei 141
Changsha 140
Hebei 140
Dublin 132
Jiaxing 123
Dearborn 122
New York 121
Norwalk 120
Tashkent 101
Abidjan 100
Ulan Bator 95
Vienna 94
Baku 92
Amman 85
Bishkek 84
Tianjin 81
Hanoi 80
Castries 77
Dushanbe 74
Managua 73
Vientiane 73
Conakry 72
Nuremberg 72
Willemstad 72
Luanda 71
Montevideo 71
Panama City 71
Riga 71
Kunming 70
Libreville 70
Lusaka 68
Jinan 67
Lima 67
Bamako 65
Harare 65
Nassau 65
Nouakchott 65
Kampala 64
Tallinn 64
Accra 63
Milan 63
Dakar 62
Kigali 61
Nairobi 61
Bridgetown 60
Praia 60
Andorra la Vella 58
Antananarivo 58
London 58
San José 58
Cotonou 57
Minsk 57
Cayenne 56
Phnom Penh 55
Podgorica 55
Rio de Janeiro 55
Kinshasa 54
Addis Ababa 53
Chicago 53
Tirana 53
Turku 53
Havana 52
Noumea 52
Ouagadougou 52
Djibouti 51
Niamey 51
Yerevan 50
Totale 36.970
Salva come PNG Salva come JPEG
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 251
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 221
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 213
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 201
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. 199
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 194
APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. 177
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 177
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma 174
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells 171
RECETTORI PER ALBUMINA UMANA POLIMERIZZATA (pHSA) SUL VIRUS DELL'EPATITE DI TIPO B : RAPPORTI CON LA ATTIVITA' REPLICATIVA DEL VIRUS 169
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 167
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 167
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 166
Squamous cell carcinoma antigen in human liver carcinogenesis. 165
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. 163
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report 163
Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus 162
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. 162
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 162
Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. 161
SERPINB3 induces epithelial-mesenchymal transition. 161
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma 159
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 159
ANTIBODY TO THE POLYALBUMIN (pHSA) RECEPTOR ON HEPATITIS B VIRUS IN ACUTE INFECTION AND IN VACCINE RECIPIENTS 157
SERPINB3, apoptosis and autoimmunity 154
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 154
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 152
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 148
Occult liver disease burden: Analysis from a large general practitioners’ database 146
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 146
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 144
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 143
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 143
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 142
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS 142
Hepatic progenitor cells express SerpinB3 142
SERPINB3 delays glomerulonephritis and attenuates the lupus-like disease in lupus murine models by inducing a more tolerogenic immune phenotype 142
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 142
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 141
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 139
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis 139
A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B 138
Expression of squamous cell carcinoma antigen in hepatocellular carcinoma and its precursors 137
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 137
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 137
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 137
Diagnostic and Prognostic Role of Scca-IgM Serum Levels in Hepatocellular Carcinoma (Hcc). 137
Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damage 136
Serpin B3 differently up-regulates hypoxia inducible factors -1α and -2α in hepatocellula arcinoma: Mechanisms revealing novel potential therapeutic targets 136
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 133
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 132
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 132
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C 131
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 131
Squamous cell carcinoma antigen in human liver carcinogenesis. 130
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 130
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 130
HEPATITIS C VIRUS SEROTYPES AND LIVER PATHOLOGY 129
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 128
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C 128
A MULTICENTRIC STUDY ON DISTRIBUTION AND CLINICAL FEATURES OF HCV GENOTYPES IN CHRONIC HEPATITIS C IN ITALY 126
Serpinb3 is overexpressed in the liver in presence of iron overload 126
AISF position paper on liver transplantation and pregnancy. Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 125
SQUAMOUS CELL CARCINOMA ANTIGEN VARIANTS OVEREXPRESSION IN HEPATOCELLULAR CARCINOMA. 124
HEPATITIS C VIRUS RNA PROFILES IN CHRONICALLY INFECTED INDIVIDUALS: DO THEY RELATE TO DISEASE ACTIVITY? 124
Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma 122
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. 122
Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. 122
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting 121
A model to predict long-term sustained response to interferon therapy in chronic hepatitis C 121
Benign mesothelial cells in lymph nodes and lymphatic spaces associated with ascites 121
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 121
Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C. 120
Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels 120
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. 119
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 119
Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology 119
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 119
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 118
"IN VITRO" LYMPHOCYTE RESPONSE TO HBcAg IN CHRONIC HBV INFECTION 116
Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. 116
Functionalized polymers to target SerpinB3 in hepatoma cells 116
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 116
Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes. 115
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 115
The protease inhibitor SERPINB3 inhibits permeability transition pore through the regulation of mitochondrial Complex I ROS production 115
A NOVEL HBV preS1[21-47]BINDING PROTEIN FOR HEP-G2 CELLS 115
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma 114
CHARACTERIZATION OF LIVER HBV-DNA FORMS ASSOCIATED WITH HBeAg TO ANTI-HBe SEROCONVERSION 113
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 113
OUTCOME OF ACUTE HEPATITIS C AND ROLE OF ALPHA INTERFERON THERAPY 113
Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. 113
Chronic evolution of acute hepatitis type B: prevalence and predictive markers 112
REACTIVATION OF CHRONIC HEPATITIS B VIRUS INFECTION 112
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 112
Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. 111
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 110
Serum hepatitis B virus DNA in acute hepatitis type B 110
Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa‐2A interferon 110
Totale 13.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.473
article - articoli 141.113
book - libri 0
conference - conferenze 0
curatela - curatele 153
other - altro 0
patent - brevetti 750
selected - selezionate 0
volume - volumi 7.435
Totale 328.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.493 0 0 109 225 108 604 92 282 813 472 357 431
2021/20226.170 89 1.174 487 545 197 266 198 627 306 102 761 1.418
2022/20234.439 1.360 319 116 360 701 581 15 280 454 32 168 53
2023/20242.053 73 247 206 132 117 168 158 61 59 60 284 488
2024/202512.414 43 823 423 363 1.700 188 529 715 1.349 465 2.336 3.480
2025/202613.511 1.185 4.570 7.756 0 0 0 0 0 0 0 0 0
Totale 57.374